While overwhelming evidence points to GLS isozymes as oncogenic proteins, underlying metabolic reprogramming leading to cancer growth and proliferation in Gln-addicted tumors, the role of GLS2 isozymes in tumor biology has not yet been elucidated and needs further clarification35. The gene discussed is GLS; the disease is cancer.